Gilig, Rocky Shann M.
HRN: 25-84-89 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/23/2025
GENTAMICIN 40MG/ML, 2ML (AMP)
03/23/2025
03/29/2025
IV
38mg
OD
Sepsis
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes